In-depth research on "replacing business tax with value-added tax" : The pharmaceutical industry can obtain benefits from three aspects

In the context of "replacing business tax with value-added tax" tax reform, the future belongs to enterprises with profit margins and good tax processing ability! China\'s "business tax to VAT" tax reform, in the original business tax levied on the service industry to levy value-added tax at the same time...

16/06-20

China\'s pharmaceutical economy winter comes spring is no longer far away

"In 2016, the focus of the pharmaceutical economy will shift from quantity to price. According to the research data of the South Institute, the total output value of China\'s pharmaceutical industry is expected to reach 2884.2 billion yuan in 2015, an increase of 11.8%; In 2016, the total industrial output value will reach...

15/11-25

Recover the cheap "life-saving drugs" that disappeared -- China\'s medical reform improves the centralized purchase of drugs to ensure the supply of drugs

The bidding and procurement of drugs is an important content and key link in deepening the reform of the medical and health system. How to reduce drug prices while ensuring drug supply, to solve the problem of clinical drug shortage? China\'s "drug reform" this year, the concentration of drugs...

15/10-08